BNB PLUS CORP (BNBX) Fundamental Analysis & Valuation
NASDAQ:BNBX • US03815U6073
Current stock price
0.6899 USD
-0.01 (-0.73%)
At close:
0.6952 USD
+0.01 (+0.77%)
After Hours:
This BNBX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. BNBX Profitability Analysis
1.1 Basic Checks
- BNBX had negative earnings in the past year.
- In the past year BNBX has reported a negative cash flow from operations.
- In the past 5 years BNBX always reported negative net income.
- BNBX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -340.95%, BNBX is not doing good in the industry: 96.43% of the companies in the same industry are doing better.
- BNBX has a worse Return On Equity (-374.65%) than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -340.95% | ||
| ROE | -374.65% | ||
| ROIC | N/A |
ROA(3y)-565.1%
ROA(5y)-366.41%
ROE(3y)-1098.28%
ROE(5y)-697.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Gross Margin value of 25.49%, BNBX is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of BNBX has declined.
- The Profit Margin and Operating Margin are not available for BNBX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 25.49% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.17%
GM growth 5Y-8.93%
2. BNBX Health Analysis
2.1 Basic Checks
- BNBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, BNBX has more shares outstanding
- The number of shares outstanding for BNBX has been increased compared to 5 years ago.
- There is no outstanding debt for BNBX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -30.51, we must say that BNBX is in the distress zone and has some risk of bankruptcy.
- BNBX has a worse Altman-Z score (-30.51) than 94.64% of its industry peers.
- BNBX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -30.51 |
ROIC/WACCN/A
WACC10.99%
2.3 Liquidity
- BNBX has a Current Ratio of 2.32. This indicates that BNBX is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of BNBX (2.32) is comparable to the rest of the industry.
- BNBX has a Quick Ratio of 2.28. This indicates that BNBX is financially healthy and has no problem in meeting its short term obligations.
- BNBX has a Quick ratio of 2.28. This is comparable to the rest of the industry: BNBX outperforms 53.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 2.28 |
3. BNBX Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 92.17% over the past year.
- The Revenue for BNBX has decreased by -45.07% in the past year. This is quite bad
- Measured over the past years, BNBX shows a small growth in Revenue. The Revenue has been growing by 2.04% on average per year.
EPS 1Y (TTM)92.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.07%
Revenue 1Y (TTM)-45.07%
Revenue growth 3Y-51.01%
Revenue growth 5Y2.04%
Sales Q2Q%-52.75%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y77.08%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year40%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. BNBX Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for BNBX. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BNBX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. BNBX Dividend Analysis
5.1 Amount
- No dividends for BNBX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BNBX Fundamentals: All Metrics, Ratios and Statistics
0.6899
-0.01 (-0.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-11 2026-02-11
Earnings (Next)05-13 2026-05-13
Inst Owners2%
Inst Owner ChangeN/A
Ins Owners3.72%
Ins Owner Change59.88%
Market Cap3.76M
Revenue(TTM)2.05M
Net Income(TTM)-70.57M
Analysts43.33
Price TargetN/A
Short Float %0.42%
Short Ratio0.13
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.83 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.2 | ||
| P/tB | 0.2 | ||
| EV/EBITDA | N/A |
EPS(TTM)-272.19
EYN/A
EPS(NY)-84.15
Fwd EYN/A
FCF(TTM)-2.74
FCFYN/A
OCF(TTM)-2.7
OCFYN/A
SpS0.38
BVpS3.46
TBVpS3.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -340.95% | ||
| ROE | -374.65% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 25.49% | ||
| FCFM | N/A |
ROA(3y)-565.1%
ROA(5y)-366.41%
ROE(3y)-1098.28%
ROE(5y)-697.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.17%
GM growth 5Y-8.93%
F-Score2
Asset Turnover0.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 52.4% | ||
| Cap/Sales | 9.56% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 2.28 | ||
| Altman-Z | -30.51 |
F-Score2
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)74.6%
Cap/Depr(5y)112.72%
Cap/Sales(3y)14.16%
Cap/Sales(5y)14.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.07%
EPS Next Y77.08%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-45.07%
Revenue growth 3Y-51.01%
Revenue growth 5Y2.04%
Sales Q2Q%-52.75%
Revenue Next Year40%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-141.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-94.11%
OCF growth 3YN/A
OCF growth 5YN/A
BNB PLUS CORP / BNBX Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for BNB PLUS CORP?
ChartMill assigns a fundamental rating of 2 / 10 to BNBX.
What is the valuation status for BNBX stock?
ChartMill assigns a valuation rating of 0 / 10 to BNB PLUS CORP (BNBX). This can be considered as Overvalued.
What is the profitability of BNBX stock?
BNB PLUS CORP (BNBX) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for BNBX stock?
The Earnings per Share (EPS) of BNB PLUS CORP (BNBX) is expected to grow by 77.08% in the next year.